Arcutis Biotherapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 3.31, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Arcutis Biotherapeutics Inc in Jun 30 2026 quarter, has decreased to 110 days, compared to 113 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 90 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 643 to 877.

What is Receivable Turnover Ratio?
What is Arcutis Biotherapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARQT Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	45.44 %	69.03 %	100.13 %	91.48 %	145.76 %
Y / Y Revenue Change	59.33 %	60.07 %	81.48 %	121.69 %	164.13 %
Receivable Turnover Ratio (TTM)	3.31	3.24	3.32	3.34	3.24
ARQT's Total Ranking	# 877	# 643	# 2404	# 744	#
Accounts Receivable average collection period days	110	112	110	109	113
Seq. Receivable Change	7.47 %	-1.27 %	27.03 %	7.9 %	24.91 %
Seq. Revenue Change	23.21 %	-18.61 %	30.52 %	21.74 %	23.78 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 91
Overall Market	# 877

Receivable Turnover Ratio Statistics
High	Average	Low
1.06	0.54	0.03
(Jun 30 2026)		(Jun 30 2023)

ARQT Company Profile • Back to ARQT Efficiency Comparisons • Compare ARQT Receivables Turnover Ratio to its Competitors

Financial Statements
Arcutis Biotherapeutics Inc 's Accounts Receivable	$ 155 Millions	Visit ARQT's Balance sheet
Arcutis Biotherapeutics Inc 's Sales TTM	$ 464 Millions	Visit ARQT's Income Statement
Sources of ARQT's Revenues		Visit ARQT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARQT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARQT's Growth Rates	ARQT's Roa	ARQT's Inventory Turnover Ratio	ARQT's Dividend Comparisons
ARQT's Profitability Ratios	ARQT's Roi	ARQT's Asset Turnover Ratio	ARQT's Dividend Growth
ARQT's Valuation Ratios	ARQT's Roe	ARQT's Financial Strength Ratios	ARQT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
X4 Pharmaceuticals Inc	8.17	$ 9.441 Millions	$ 1.156 Millions
Adapthealth Corp	8.14	$ 3,226.709 Millions	$ 396.643 Millions
Seastar Medical Holding Corp	8.11	$ 1.713 Millions	$ 0.211 Millions
Bioage Labs Inc	8.09	$ 10.355 Millions	$ 1.280 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Concentra Group Holdings Parent Inc	8.07	$ 2,287.465 Millions	$ 283.300 Millions
Sanuwave Health Inc	8.04	$ 43.903 Millions	$ 5.461 Millions
Sight Sciences Inc	8.04	$ 83.351 Millions	$ 10.368 Millions
Aveanna Healthcare Holdings Inc	8.03	$ 2,602.820 Millions	$ 324.026 Millions
Sotera Health Company	8.01	$ 1,215.925 Millions	$ 151.745 Millions
Avita Medical Inc	7.99	$ 75.631 Millions	$ 9.463 Millions
Alphatec Holdings Inc	7.94	$ 814.780 Millions	$ 102.662 Millions
Tenet Healthcare Corp	7.92	$ 21,812.000 Millions	$ 2,752.500 Millions
Henry Schein Inc	7.91	$ 13,602.000 Millions	$ 1,719.000 Millions
Becton Dickinson And Company	7.90	$ 20,840.000 Millions	$ 2,639.250 Millions
Tela Bio Inc	7.86	$ 80.535 Millions	$ 10.243 Millions
Pacs Group Inc	7.78	$ 5,551.038 Millions	$ 713.483 Millions
Trisalus Life Sciences Inc	7.78	$ 45.179 Millions	$ 5.808 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Lemaitre Vascular Inc	7.65	$ 262.923 Millions	$ 34.370 Millions
Idexx Laboratories Inc	7.65	$ 4,553.792 Millions	$ 595.549 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Acadia Pharmaceuticals Inc	7.56	$ 1,138.643 Millions	$ 150.596 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Protalix Biotherapeutics inc	7.55	$ 80.619 Millions	$ 10.677 Millions
Aurinia Pharmaceuticals Inc	7.55	$ 311.507 Millions	$ 41.274 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Novocure Limited	7.46	$ 699.193 Millions	$ 93.686 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions

Date modified: 2026-09-09T00:21:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.